All Industries

Top Synthetic Biology Companies

51 Synthetic Biology companies, sorted by total funding raised.

51

Companies

$2.5B

Combined Funding

Seed

Top Stage

Indexed tracks 51 Synthetic Biology companies that have collectively raised $2.5B in documented funding. The most-funded synthetic biology companies tracked include Ginkgo Bioworks and DNA Script. Seed is the most common funding stage among synthetic biology companies in this dataset.

Ginkgo BioworksIPO

Ginkgo Bioworks operates autonomous laboratories that use robotics to run experimental work, help...

Boston, United States501–1000Automation, Diagnostics
Extension RoundTotal funding$790.0MMay 2020
DNA Script

DNA Script develops the SYNTAX platform for enzymatic DNA synthesis, enabling labs to print high-...

Paris, France51–200Biotech, Synthetic Biology
Series CTotal funding$466.5MJan 2022
Opentrons

Opentrons develops accessible laboratory robots and automation tools that help scientists reduce ...

New York, United States201–500Biotech, Healthcare
Extension RoundTotal funding$260.8MNov 2025
Antheia, Inc.

R&D company with 5 SBIR/STTR awards from National Science Foundation, Department of Health and Hu...

Menlo Park, United States1–10Biotech, Healthcare
Series CTotal funding$228.0MJan 2026
Molecular AssembliesAcquired

Molecular Assemblies develops Fully Enzymatic Synthesis technology to produce long, pure DNA olig...

San Diego, United States51–200Biotech, Synthetic Biology
Venture RoundTotal funding$135.4MApr 2025
Ansa Biotechnologies

Ansa Biotechnologies uses enzymatic DNA synthesis to build complex custom sequences up to 50 kb f...

Emeryville, United States51–200Biotech, Healthcare
Series BTotal funding$132.6MOct 2025
Bota Bio

Industrial synthetic biotechnology company developing bio-based manufacturing solutions for consu...

Hangzhou, China51–200Biotech, Synthetic Biology
Series BTotal funding$115.0MJul 2021
Tentarix Biotherapeutics

Creates innovative protein therapeutics leveraging synthetic biology

San Diego, United States11–50Biotech, Oncology
Series BTotal funding$85.0MSep 2023
FabricNano

Transforms industrial chemical processes into cell-free biomanufacturing using enzymatic catalysi...

London, United Kingdom1–10Biotech, Synthetic Biology
Series BTotal funding$62.5MSep 2022
Living Carbon

Living Carbon restores degraded land through reforestation, generating carbon removal credits for...

Charleston, United States11–50Agtech, Biotech
Venture RoundTotal funding$49.5MApr 2026
ZBiotics

ZBiotics makes the world's first genetically engineered probiotic, designed to break down acetald...

San Francisco, United States11–50Food & Beverage, Healthcare
Series ATotal funding$39.5MAug 2024
Lygos

Lygos engineers yeast to convert sugar into high-value industrial…

San Francisco, United States51–200Biotech, Climate Tech
Venture RoundTotal funding$38.6MJan 2019
bitBiome

bitBiome offers enzyme discovery and engineering from a proprietary microbial single-cell genome ...

Tokyo, Japan11–50Biotech, Genomics
Extension RoundTotal funding$28.8MMay 2026
ACX

ACX develops bioengineered crop-protection solutions that reduce chemical dependence and promote ...

New York, United States1–10Agtech, Biotech
Pre-seedTotal funding$15.5MOct 2024
inSoma Bio

inSoma Bio develops unique products that enable reconstructive plastic surgeons to use a person's...

Durham, United States1–10Healthcare, Medical Devices
ConvertibleTotal funding$11.7MOct 2025
Adaptyv

Adaptyv builds automated technologies that let protein engineers design and test new proteins for...

Lausanne, Switzerland11–50Drug Discovery, Healthcare
SeedTotal funding$10.8MJan 2024
Genecis Bio

Genecis turns organic waste into biodegradable PHA materials for partners developing sustainable ...

Toronto, Canada11–50Biotech, Clean Tech
Extension RoundTotal funding$10.5MFeb 2023
Pow.bio

Biomanufacturing for a Growing World

Alameda, United States11–50Artificial Intelligence, Biotech
Series ATotal funding$9.5MOct 2023
Abalone Bio

We discover antibody drugs others can't

Emeryville, United States11–50Drug Discovery, Healthcare
GrantTotal funding$7.6MApr 2024
Scentian Bio

Biotech spinout from Plant & Food Research harnessing insect smell receptors for novel biosensor ...

New Zealand11–50Biotech, Synthetic Biology
Series ATotal funding$7.3MJan 2020
LEAH Labs

LEAH Labs engineers CAR-T cell therapy to fight cancer in pet dogs, combining gene editing with p...

Minneapolis, United States1–10Drug Discovery, Healthcare
GrantTotal funding$7.1MAug 2025
Granza Bio

Advancing Therapeutic Delivery

San Francisco, United States1–10Biotech, Healthcare
SeedTotal funding$7.1MJul 2024
Genome CompilerAcquired

Market-Network for synthetic biology industry

Tel Aviv, Israel1–10Biotech, Marketplace
SeedTotal funding$6.0MApr 2016
Sensible Biotechnologies

Sensible Biotechnologies offers a cell-based mRNA design and manufacturing platform that enables ...

Oxford, United Kingdom11–50Biotech, Healthcare
Pre-seedTotal funding$4.2MApr 2023
General Biological

Synthetic biology company developing sustainable bioproduction technology to replace petrochemica...

New Haven, United States1–10Biotech, Synthetic Biology
SeedTotal funding$3.0MMar 2026

Frequently Asked Questions

How many Synthetic Biology companies are tracked on Indexed?

Indexed tracks 51 Synthetic Biology companies, sorted by total funding raised.

How much funding have Synthetic Biology companies raised in total?

The Synthetic Biology companies tracked by Indexed have collectively raised $2.5B in documented funding.

What are the top-funded Synthetic Biology companies?

The most-funded Synthetic Biology companies tracked include Ginkgo Bioworks, DNA Script, Opentrons.

Who are the top investors in Synthetic Biology?

Leading investors active in Synthetic Biology include IndieBio, Casdin Capital, IQ Capital Partners.

Explore More

Other Industries